Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Potter

Showing results (721-730 of 778) with videos related to

Pageof 78
Sort By:
Molecular Cancer Therapeutics|August 30, 2008
Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallographyL W Lawrence Woo, Delphine S Fischer, Christopher M Sharland, et al.
Pediatric Blood & Cancer|October 18, 2016
Renal cell carcinoma harboring somatic TSC2 mutations in a child with methylmalonic acidemiaSamara L Potter, Rajkumar Venkatramani, Scott Wenderfer, et al.
Neuro-Oncology Advances|July 22, 2024
Germline susceptibility from broad genomic profiling of pediatric brain cancersElaine R Mardis, Samara L Potter, Kathleen M Schieffer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitorSusannah J Stanway, Atul Purohit, L W Lawrence Woo, et al.
Metabolism: Clinical and Experimental|December 6, 2024
Inhibiting IP6K1 confers atheroprotection by elevating circulating apolipoprotein A-IXiaoqi Liu, Zixuan Zhang, Tim Aguirre, et al.
Life Sciences|June 7, 2025
Protective potential of Irosustat, STX140 and the sulfonate derivative 1G in counteracting cisplatin-induced renal and hepatic toxicities: An in vivo comparative studyHanan S Anbar, Aseel W Radi, Haidi A Shaker, et al.
Annals of Surgical Oncology|May 11, 2026
ASO Visual Abstract: Do Postoperative Complications Impact Adjuvant Chemotherapy for Patients Undergoing Left-Side Pancreatectomy for Pancreatic Cancer?Dillon C Cheung, Stephanie Yu, Chee-Chee Stucky, et al.
Annals of Surgical Oncology|May 2, 2026
Do Postoperative Complications Impact Adjuvant Chemotherapy in Patients Undergoing Left-Side Pancreatectomy for Pancreatic Cancer?Dillon C Cheung, Stephanie Yu, Chee-Chee Stucky, et al.
The Journal of Infection|May 29, 2012
Guidelines for the public health management of typhoid and paratyphoid in England: practice guidelines from the National Typhoid and Paratyphoid Reference GroupS Balasegaram, A L Potter, D Grynszpan, et al.
Chemical Communications (Cambridge, England)|April 14, 2010
Chimeric microtubule disruptorsMathew P Leese, Fabrice Jourdan, Meriel R Kimberley, et al.
Pageof 78

Showing results (721-730 of 778) with videos related to

Sort By:
Pageof 78
Molecular Cancer Therapeutics|August 30, 2008
Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallographyL W Lawrence Woo, Delphine S Fischer, Christopher M Sharland, et al.
Pediatric Blood & Cancer|October 18, 2016
Renal cell carcinoma harboring somatic TSC2 mutations in a child with methylmalonic acidemiaSamara L Potter, Rajkumar Venkatramani, Scott Wenderfer, et al.
Neuro-Oncology Advances|July 22, 2024
Germline susceptibility from broad genomic profiling of pediatric brain cancersElaine R Mardis, Samara L Potter, Kathleen M Schieffer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitorSusannah J Stanway, Atul Purohit, L W Lawrence Woo, et al.
Metabolism: Clinical and Experimental|December 6, 2024
Inhibiting IP6K1 confers atheroprotection by elevating circulating apolipoprotein A-IXiaoqi Liu, Zixuan Zhang, Tim Aguirre, et al.
Life Sciences|June 7, 2025
Protective potential of Irosustat, STX140 and the sulfonate derivative 1G in counteracting cisplatin-induced renal and hepatic toxicities: An in vivo comparative studyHanan S Anbar, Aseel W Radi, Haidi A Shaker, et al.
Annals of Surgical Oncology|May 11, 2026
ASO Visual Abstract: Do Postoperative Complications Impact Adjuvant Chemotherapy for Patients Undergoing Left-Side Pancreatectomy for Pancreatic Cancer?Dillon C Cheung, Stephanie Yu, Chee-Chee Stucky, et al.
Annals of Surgical Oncology|May 2, 2026
Do Postoperative Complications Impact Adjuvant Chemotherapy in Patients Undergoing Left-Side Pancreatectomy for Pancreatic Cancer?Dillon C Cheung, Stephanie Yu, Chee-Chee Stucky, et al.
The Journal of Infection|May 29, 2012
Guidelines for the public health management of typhoid and paratyphoid in England: practice guidelines from the National Typhoid and Paratyphoid Reference GroupS Balasegaram, A L Potter, D Grynszpan, et al.
Chemical Communications (Cambridge, England)|April 14, 2010
Chimeric microtubule disruptorsMathew P Leese, Fabrice Jourdan, Meriel R Kimberley, et al.
Pageof 78